47 related articles for article (PubMed ID: 31498074)
1. Associations between certolizumab pegol serum levels, anti-drug antibodies and treatment response in patients with inflammatory joint diseases: data from the NOR-DMARD study.
Gehin JE; Goll GL; Warren DJ; Syversen SW; Sexton J; Strand EK; Kvien TK; Bolstad N; Lie E
Arthritis Res Ther; 2019 Nov; 21(1):256. PubMed ID: 31783773
[TBL] [Abstract][Full Text] [Related]
2. Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network.
Larid G; Baudens G; Tiemdjo-Djimaffo G; Coquerelle P; Goeb V; Guyot MH; Marguerie L; Maury F; Veillard E; Houvenagel E; Salmon JH; Flipo RM; Gervais E
Sci Rep; 2024 Jan; 14(1):1374. PubMed ID: 38228719
[TBL] [Abstract][Full Text] [Related]
3. Drug Retention Rate and Factors Associated with Discontinuation of Interleukin-17 Inhibitors in Patients with Axial Spondyloarthritis.
Kwon OC; Park MC
Yonsei Med J; 2023 Dec; 64(12):697-704. PubMed ID: 37992741
[TBL] [Abstract][Full Text] [Related]
4. Certolizumab-induced optic neuritis in a patient with spondyloarthritis: A case report and review of the literature.
Boussaa H; Nouicer S; Miladi S; Makhlouf Y; Ben Abdelghani K; Fazaa A; Laatar A
Therapie; 2023 Nov; ():. PubMed ID: 38158272
[No Abstract] [Full Text] [Related]
5. Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience.
Bilgin E; Ceylan F; Duran E; Farisoğullari B; Bölek EÇ; Yardimci GK; Kiliç L; Akdoğan A; Karadağ Ö; Apraş Bilgen ŞŞ; Kiraz S; Ertenli Aİ; Kalyoncu U
Turk J Med Sci; 2021 Feb; 51(1):297-308. PubMed ID: 32979899
[TBL] [Abstract][Full Text] [Related]
6. Imaging modalities used in diagnosis and follow-up of patients with Takayasu’s arteritis.
Keleşoğlu Dinçer AB; Kılıç L; Erden A; Kalyoncu U; Hazirolan T; Kiraz S; KaradaĞ Ö
Turk J Med Sci; 2021 Feb; 51(1):224-230. PubMed ID: 33155792
[TBL] [Abstract][Full Text] [Related]
7. QuantiFERON®-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guérin (BCG)-vaccinated country: the HUR-BIO single-center real-life results.
Seyhoglu E; Uyaroğlu OA; Erden A; Kilic L; Karadag O; Akdogan A; Bilgen SA; Ertenli I; Kiraz S; Kalyoncu U
Clin Rheumatol; 2021 May; 40(5):2027-2035. PubMed ID: 33057917
[TBL] [Abstract][Full Text] [Related]
8. Is Takayasu's arteritis more severe in children?
Bolek EC; Kaya Akca U; Sari A; Sag E; Demir S; Kilic L; Sener YZ; Aykan HH; Kaya EB; Bilginer Y; Akdogan A; Kiraz S; Karadag O; Ozen S
Clin Exp Rheumatol; 2021; 39 Suppl 129(2):32-38. PubMed ID: 32940211
[TBL] [Abstract][Full Text] [Related]
9. Predictors of persistent inflammation in familial Mediterranean fever and association with damage.
Babaoglu H; Armagan B; Bodakci E; Satis H; Atas N; Sari A; Yasar Bilge NS; Bilici Salman R; Yardımcı GK; Avanoglu Guler A; Karadeniz H; Kilic L; Ozturk MA; Goker B; Haznedaroglu S; Kalyoncu U; Kasifoglu T; Tufan A
Rheumatology (Oxford); 2021 Jan; 60(1):333-339. PubMed ID: 32778893
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience.
Bolek EC; Sari A; Kilic L; Kalyoncu U; Kurne A; Oguz KK; Topcuoglu MA; Ertenli I; Karadag O
Mult Scler Relat Disord; 2020 Feb; 38():101512. PubMed ID: 31733425
[TBL] [Abstract][Full Text] [Related]
11. Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.
Farisoğulları B; Yardımcı GK; Sarı A; Bilgin E; Bölek EÇ; Duran E; Kılıç L; Akdoğan A; Karadağ Ö; Apraş Bilgen Ş; Ertenli Aİ; Kiraz S; Kalyoncu U
Clin Exp Rheumatol; 2022 Jan; 40(1):112-119. PubMed ID: 33635221
[TBL] [Abstract][Full Text] [Related]
12. A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis.
Coto-Segura P; Segú-Vergés C; Martorell A; Moreno-Ramírez D; Jorba G; Junet V; Guerri F; Daura X; Oliva B; Cara C; Suárez-Magdalena O; Abraham S; Mas JM
Front Immunol; 2023; 14():1212981. PubMed ID: 37809085
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Certolizumab-Pegol in Rheumatoid Arthritis, Spondyloarthritis, and Psoriatic Arthritis Based on the BIOPURE Registry: Can Early Response Predict Late Outcomes?
Iannone F; Semeraro A; Carlino G; Santo L; Bucci R; Quarta L; Maruotti N; Zuccaro C; Marsico A; Falappone PCF; Mazzotta D; Cantatore FP; Muratore M; Lapadula G
Clin Drug Investig; 2019 Jun; 39(6):565-575. PubMed ID: 30941736
[TBL] [Abstract][Full Text] [Related]
14. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
van der Heijde D; Dougados M; Landewé R; Sieper J; Maksymowych WP; Rudwaleit M; Van den Bosch F; Braun J; Mease PJ; Kivitz AJ; Walsh J; Davies O; Bauer L; Hoepken B; Peterson L; Deodhar A
Rheumatology (Oxford); 2017 Sep; 56(9):1498-1509. PubMed ID: 28498975
[TBL] [Abstract][Full Text] [Related]
15. Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol.
Maksymowych WP; Kumke T; Auteri SE; Hoepken B; Bauer L; Rudwaleit M
Arthritis Res Ther; 2021 Oct; 23(1):274. PubMed ID: 34715908
[TBL] [Abstract][Full Text] [Related]
16. Certolizumab pegol for treating axial spondyloarthritis.
Desmarais J; Beier S; Deodhar A
Expert Opin Biol Ther; 2016 Aug; 16(8):1059-64. PubMed ID: 27366922
[TBL] [Abstract][Full Text] [Related]
17. Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases.
Deeks ED
BioDrugs; 2016 Dec; 30(6):607-617. PubMed ID: 27704400
[TBL] [Abstract][Full Text] [Related]
18. Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry.
Bilgin E; Farisoğulları B; Armağan B; Sarı A; Yardımcı GK; Bölek EÇ; Kılıç L; Akdoğan A; Bilgen ŞA; Karadağ Ö; Ertenli Aİ; Kiraz S; Kalyoncu U
Clin Exp Rheumatol; 2020; 38(4):609-614. PubMed ID: 31498074
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
